PUBLISHER: The Business Research Company | PRODUCT CODE: 2112381
PUBLISHER: The Business Research Company | PRODUCT CODE: 2112381
Revascularization devices are medical technologies intended to restore or enhance circulation in blood vessels that have become narrowed or obstructed. These devices are frequently utilized in the treatment of conditions such as coronary artery disease and peripheral artery disease. They function by reopening blocked vessels or creating alternative pathways around obstructions, ensuring sufficient delivery of oxygenated blood to tissues and organs.
The primary product categories of revascularization devices include atherectomy devices, balloon angioplasty catheters, bare metal stents, drug-coated balloons, drug-eluting stents, and everolimus-eluting stents. Atherectomy devices are minimally invasive medical tools designed to remove plaque accumulation from blood vessels and improve blood circulation. These devices are produced using materials such as bioabsorbable scaffolds, metallic materials, cobalt chromium, platinum chromium, stainless steel, and polymers. Their applications include coronary interventions, peripheral vascular interventions, neurovascular interventions, and renal artery interventions, and they are employed by hospitals, cardiac catheterization laboratories, ambulatory surgical centers, specialty cardiovascular clinics, and research and academic institutions.
Tariffs are influencing the revascularization devices market by increasing the cost of imported medical-grade components such as stent platforms, balloon catheter assemblies, imaging-compatible metals, and polymer-based drug delivery systems used in cardiovascular interventions. This is leading to higher procedural costs and procurement pressure on healthcare systems, particularly in import-dependent regions such as Asia-Pacific and parts of Latin America where advanced interventional cardiology devices are heavily sourced from global manufacturers. Hardware-intensive segments like drug-eluting stents, atherectomy devices, and advanced balloon angioplasty catheters are most affected due to complex global supply chains and reliance on precision manufacturing hubs in North America and Europe. However, tariffs are also promoting localized manufacturing of vascular devices, strengthening regional MedTech ecosystems, and encouraging companies to diversify suppliers and invest in cost-optimized innovation for long-term market resilience.
The revascularization device market size has grown strongly in recent years. It will grow from $3.88 billion in 2025 to $4.24 billion in 2026 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to rising prevalence of coronary artery disease, growing aging population globally, expansion of catheterization laboratories, increasing adoption of drug eluting stents, improvements in interventional cardiology techniques.
The revascularization device market size is expected to see strongly grown in the next few years. It will grow to $6.1 billion in 2030 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to growth in precision guided vascular interventions, rising demand for minimally invasive surgeries, integration of ai assisted interventional imaging, expansion of ambulatory surgical centers, increasing focus on bioresorbable and next generation stents. Major trends in the forecast period include minimally invasive revascularization procedures expansion, bioresorbable scaffold adoption in vascular repair, advanced imaging guided vascular interventions, radial access based cardiovascular procedures growth, outpatient shift toward ambulatory vascular treatment.
The rising prevalence of cardiovascular diseases is expected to propel the growth of the revascularization device market going forward. Cardiovascular diseases (CVDs) refer to a group of disorders affecting the heart and blood vessels, including conditions such as coronary artery disease, stroke, heart failure, and hypertension. The rising prevalence of cardiovascular diseases is primarily due to unhealthy lifestyles, which negatively affect heart health and increase the risk of developing heart-related disorders. Revascularization device helps in cardiovascular diseases by restoring and improving blood flow through blocked or narrowed arteries, thereby reducing ischemia and preventing complications such as heart attack and stroke. For instance, in March 2025, according to the Joint Strategic Needs Assessment, a UK-based community health center, the number of deaths caused by cardiovascular disease (CVD) was 185 in 2023, compared to 178 recorded in 2022. Therefore, the increasing prevalence of cardiovascular diseases is driving the growth of the revascularization device market.
Key companies operating in the revascularization device market are focusing on the development of innovative products, such as next-generation intermediate catheters, to enhance blood vessel access, improve clot retrieval efficiency, and increase procedural success rates in minimally invasive stroke interventions. Intermediate catheters are flexible, large-lumen medical devices used during endovascular procedures to navigate cerebral and peripheral vasculature, facilitate aspiration or delivery of treatment devices, and support rapid revascularization in patients experiencing acute ischemic stroke. For example, in February 2024, Cerenovus Inc., a US-based neurovascular company, introduced the Cereglide 71 Intermediate Catheter designed for revascularization in patients with acute ischemic stroke. The device features a large inner lumen to support efficient clot removal, enhanced flexibility for navigation through tortuous vessels, and optimized wall construction to balance support and deliverability. It is intended to improve procedural efficiency in mechanical thrombectomy procedures and support faster reperfusion outcomes in time-critical stroke care scenarios.
In September 2024, Boston Scientific Corporation, a US-based medical technology company, acquired Silk Road Medical for $1.18 billion. With this acquisition, Boston Scientific aimed to strengthen its neurovascular and stroke intervention portfolio by expanding into transcarotid artery revascularization (TCAR) technologies and accelerating its presence in the carotid artery disease treatment space. Silk Road Medical Inc. is a US-based company focused on developing revascularization devices for the treatment of carotid artery disease.
Major companies operating in the revascularization device market are Johnson & Johnson; Abbott Laboratories; Medtronic plc; Boston Scientific Corporation; Becton Dickinson and Company; Stryker Corporation; Terumo Corporation; W. L. Gore & Associates Inc.; Cook Medical LLC; Teleflex Incorporated; Asahi Intec Co. Ltd.; MicroPort Scientific Corporation; Biotronik SE & Co. KG; Penumbra Inc.; Lepu Medical Technology Co Ltd.; Merit Medical Systems Inc.; AngioDynamics Inc.; Cordis Corporation; MicroVention Inc.; OrbusNeich Medical Company Limited; Meril Life Sciences Pvt. Ltd.; Acotec Scientific Holdings Limited; Zylox-Tonbridge Medical Technology Co Ltd.; iVascular S.L.U.
North America was the largest region in the revascularization device market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the revascularization device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the revascularization device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The revascularization device market consists of sales of thrombectomy devices, embolic protection devices, intravascular imaging systems, vascular closure devices, and guiding catheters. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
The revascularization device market research report is one of a series of new reports from The Business Research Company that provides revascularization device market statistics, including revascularization device industry global market size, regional shares, competitors with a revascularization device market share, detailed revascularization device market segments, market trends and opportunities, and any further data you may need to thrive in the revascularization device industry. This revascularization device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Revascularization Device Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses revascularization device market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for revascularization device ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The revascularization device market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.